Analysis of fumonisin B1-induced apoptosis. by Jones, C et al.
Environmental Health Perspectives • VOLUME 109 | SUPPLEMENT 2 | May 2001 315
Introduction 
Fusarium moniliforme is a significant plant
pathogen that primarily infects corn but can
also infect rice and wheat [reviewed in (1–7)].
The fungus is widespread and produces a
variety of mycotoxins; the major class is called
fumonisin. Several subtypes of fumonisin
have been identified (A, B, or C), and all
these compounds resemble sphingolipids
[reviewed in (8–10)]. FB1 inhibits sphingo-
sine N-acetyltransferase (ceramide synthase)
and thus blocks sphingolipid biosynthesis.
FB1 and FB2 are of toxicologic significance
because they are present at high concentra-
tions on diseased plants and are frequently
detected on healthy corn plants (11). 
Ingestion of moldy corn infected by
F. moniliforme or closely related fungi is
linked to a higher incidence of primary liver
cancer (12) and esophageal cancer in regions
of South Africa and China (13). In rats fed a
diet containing 50 mg/kg FB1, primary hepa-
tocellular carcinoma occurred in two thirds of
the animals (14–16). FB1 is also a potent
tumor promoter in rat liver after initiation
with diethylnitrosamine (17). Cancer-pro-
moting activity has occurred at levels that did
not induce liver or kidney toxicity and, fur-
thermore, did not initiate cancer.
Culture material from F. moniliforme con-
taining FB1 induces equine leukoencephalo-
malacia and nephrotoxicity (18). Purified
preparations of FB1 are also hepatotoxic (19),
cause porcine pulmonary edema (20), and
are nephrotoxic to several animal species
(21–23). In vivo studies have demonstrated
that FB1 induces apoptosis in rat kidney and
liver (24–26). FB1 also induces apoptosis of
several different mammalian cell types
(26–29), demonstrating that treatment can
lead directly to apoptosis. A previous study
demonstrated that neoplastic African green
monkey kidney cells (COS-7) are resistant to
the apoptotic and antiproliferative effects of
FB1 compared to their normal counterparts,
African green monkey kidney cells (CV-1)
(29,30). Murine or human leukemia cells do
not undergo apoptosis when treated with FB1
(30,31). We have also found that other cell
lines derived from human tumors are resis-
tant to the effects of FB1 (data not shown).
Taken together, these studies suggested that
transformed cells, in general, are resistant to
the effects of FB1. Because the ability of cells
to escape apoptosis plays a critical role in the
development of cancer, the ability of FB1 to
induce apoptosis may select for cells resistant
to apoptosis. It is hypothesized that these cells
would have altered growth capabilities.
The goal of this study was to characterize
FB1-induced apoptosis. A previous study
demonstrated that cyclin-dependent kinase
(cdk) activity increased slightly after 3 hr of
FB1 treatment but then declined (30). This is
significant because cdk activity transiently
increases during the early stages of apoptosis
(32). Further studies confirmed that cdk2
activity transiently increased after FB1 treat-
ment. Several pathways have been identiﬁed
that result in programmed cell death or
apoptosis [reviewed in (33)]. A quantitative
assay for apoptosis was used to identify spe-
cific genes that interfere with FB1-induced
apoptosis. This assay indicated that a bac-
ulovirus gene (CpIAP) inhibited FB1-induced
apoptosis. Because CpIAP inhibits tumor
necrosis factor (TNF)-induced apoptosis, we
further examined other factors involved in
TNF signal transduction pathways. A caspase
involved with TNF-induced apoptosis (cas-
pase 8) was cleaved and activated within 2 hr
after treatment. In contrast, nuclear factor
kappa-B (NF-κB), a transcription factor
downstream of the TNF receptor (TNFR)
but independent of the apoptotic pathway
was not activated following FB1 treatment.
Taken together, this study suggested that the
TNF signal transduction pathway (directly or
indirectly) plays a role in FB1-induced apop-
tosis. Further studies will be necessary to
prove that the TNFR or downstream factors
are directly affected by FB1.
Materials and Methods
Cells Lines and Media 
CV-1 cells were split at 1:5 ratio every 5 days.
Mouse embryo ﬁbroblasts (MEF) with a dis-
rupted p53 gene (p53–/–) were obtained from
E. Lee (University of Texas Southwestern
Medical Center, San Antonio, Texas, USA)
and T. Jacks (Massachusetts Institute of
Technology, Cambridge, MA, USA). Normal
MEF were prepared from Balb/C mice. MEF
were split 5–7 times and then discarded. Cells
were grown in Earle’s modified Eagle’s
medium supplemented with 5% fetal bovine
serum (FBS), penicillin (10 U/mL), and
streptomycin (100 µg/mL) and were plated at
a density of 5 ￿105 cells/100-mm plastic dish.
Fumonisins are mycotoxins produced by Fusarium moniliforme, a prevalent fungus that infects corn
and other cereal grains. Fumonisin B1 (FB1) is the most common mycotoxin produced by F.
moniliforme, suggesting it has toxicologic signiﬁcance. The structure of FB1 resembles sphingoid
bases, and it inhibits ceramide synthase. Because sphingoid bases regulate cell growth,
differentiation, transformation, and apoptosis, it is not surprising to ﬁnd that FB1 can alter growth of
certain mammalian cells. Previous studies concluded FB1-induced apoptosis, or cell cycle arrest, in
African green monkey kidney ﬁbroblasts (CV-1). In this study we have identiﬁed genes that inhibit
FB1-induced apoptosis in CV-1 cells and two mouse embryo ﬁbroblasts (MEF). A baculovirus gene,
inhibitor of apoptosis (CpIAP), protected these cells from apoptosis. CpIAP blocks apoptosis
induced by the tumor necrosis factor (TNF) pathway as well as other mechanisms. Further support
for the involvement of the TNF signal transduction pathway in FB1-induced apoptosis was the
cleavage of caspase 8. Inhibition of caspases by the baculovirus gene p35 also inhibited FB1-
induced apoptosis. The tumor suppressor gene p53 was not required for FB1-induced apoptosis
because p53–/– MEF undergo apoptosis following FB1 treatment. Furthermore, Bcl-2 was not an
effective inhibitor of FB1-induced apoptosis in CV-1 cells or p53+/+ MEF. In summary, these results
provide new information to help understand the mechanism by which FB1 induces apoptosis. Key
words: apoptosis, fumonisin B1, mycotoxins, signal transduction, tumor necrosis factor. — Environ
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Fumonisin B1
FB1 was obtained from R. Eppley (U.S. Food
and Drug Administration, Washington, DC,
USA) (> 99% pure) and was dissolved in cal-
cium and magnesium-free, phosphate-
buffered saline (PBS) (80 mM Na2HPO4; 20
mM NaH2PO4; 100 mM NaCl, pH 7.5).
Three hours after the cells were plated, FB1
was added to the media at a concentration of
5 or 25 µM.
Bluo-gal Co-Transfection and Analysis
of Cell Death
Cells were plated at a density of 2 ￿ 105/well
in 6-well plastic plates (35 mm/well) 12–16 hr
prior to the transfection. Cells were then trans-
fected with plasmid DNA containing the
β-galactosidase gene [cytomegalovirus (CMV-
β-gal)] by the calcium phosphate method (34).
Samples were co-transfected with a mam-
malian expression plasmid that inﬂuences cell
growth or apoptosis. A description of these
plasmids is presented below. For each 35-mm
well, 250 µL calcium phosphate solution (125
mM CaCl2; 25 mM HEPES–NaOH, pH 7.1;
0.75 mM Na2HPO4–NaH2PO4, pH 7.0; 125
mM NaCl) and plasmid DNA mix were
added to the cells. Five hours after transfection,
cells were shocked with PBS in 20% glycerol
for 4 min, then washed with PBS twice. Fresh
medium containing 5% fetal calf serum and 5
mM sodium butyrate was added to the cells.
Cells were incubated at 37°C for 16 hr, then
passaged at a 1:5 ratio onto a 24-well dish.
These cells were treated with 25 µM FB1 or 20
µM C6-ceramide (37°C for 48 hr), and β-gal
expression was analyzed as described previously
(27,35). Briefly, cells were rinsed with PBS,
ﬁxed with 2% formaldehyde, 0.2% glutaralde-
hyde in PBS for 5 min, then washed twice
with PBS. Fixed cells were stained for 6–24 hr
with 0.1% Bluo-gal (Gibco, Rockville, MD,
USA) in a PBS solution containing 5 mM
potassium ferrocyanide, 5 mM potassium ferri-
cyanide, and 2 mM MgCl2. After being rinsed
in PBS, positive cells were observed microscop-
ically and the number of stained blue cells
counted. At least five fields per plate were
counted, and the average number of cells per
ﬁeld was calculated.
Plasmids
pCMVCpIAP and pcDNA3/p35 are plas-
mids that contain baculovirus anti-apoptotic
genes (36); these plasmids were obtained
from L. Miller (University of Georgia,
Athens, GA, USA). pcDNA/crmA (37)
encodes a cowpox virus protein inhibitor of
caspases and was obtained from L. Lou
(University of Michigan Medical School,
Ann Arbor, MI, USA). The adenovirus E1A
or E1B 55-kDa encode proteins that bind
Rb or p53, respectively, and were obtained
from E. White (Rutgers University,
Piscataway, NJ, USA). The expression vector
that encodes Bcl-2 was obtained from J.
Reed (La Jolla Cancer Research Center, La
Jolla, CA, USA). CMV-β-gal was purchased
from Clontech (Palo Alto, CA, USA).
Human immunodeﬁciency virus (HIV) long
terminal repeat (LTR) and HIV∆NFkB were
obtained form C. Wood (University of
Nebraska, Lincoln, NE, USA). Plasmid
preparations were obtained by cesium
chloride puriﬁcation (38).
Nuclear DNA Fragmentation Analysis
Cell cultures were treated with 5 µM FB1 for
6, 12, 24, or 48 hr. Cells were then collected
with a plastic cell scraper, suspended in
TKMC buffer (10 mM Tris, pH 7.5; 10 mM
KCl; 1 mM MgCl2; 5 mM CaCl2) contain-
ing 0.5% TX-100. Cells were lysed by treat-
ment with 150 µg/mL of proteinase K, 100
mg RNAse A, and 0.1% sodium dodecyl sul-
fate (SDS). Genomic DNA was extracted
with a phenol–chloroform–isoamyl alcohol
solution (50:49:1). DNA samples were elec-
trophoresed in a 1.5% agarose gel using TBE
(0.1 M Tris, 0.1 M boric acid, 0.025 M
EDTA, pH 8.3). DNA in the agarose gel was
denatured with 1.5 M NaCl, 0.5 M NaOH
for 30 min at room temperature, then neu-
tralized by incubating with 3.0 M NaCl and
0.5 M Tris, pH 5.2, for 25 min. After the
neutralization step was repeated, gels were
rinsed in 2￿ SSC) (20 ￿ SSC is 3 M NaCl
and 0.3 M citric acid) and blotted onto a
nylon membrane (Hy Bond+, Amersham).
The DNA transferred to the membrane was
hybridized with a monkey genomic DNA
probe. The probe was radiolabeled by
random priming method with 32P by an
enzymatic reaction catalyzed by the Klenow
enzyme (New England Biolabs, Beverly,
MA, USA). Prehybridization was performed
at 65°C in 5￿ SSPE (0.75 M NaCl, 0.05 M
sodium phosphate, 0.005 M EDTA),
0.5% bovine serum albumin, 0.5%
polyvinylpyrrolidone and 1% SDS for 2 hr.
Hybridization was carried out for 6–18 hr at
65°C by using 2 ￿ 107 dpm of radiolabeled
probe diluted in hybridization buffer. Filters
were washed 3 times at room temperature
and once at 65°C for 30 min in 1￿ SSPE,
1% SDS. Filters were then dried and
exposed to ﬁlm.
Measurement of Cyclin-Dependent
Kinase Activity
Dishes were washed with PBS and cells were
collected, and suspended in 500 µL of lysis
buffer (20 mM HEPES, pH 7.9; 0.4 M
NaCl; 1 mM EDTA; 10 mM dithiothreitol;
1 mM phenylmethylsulfonyl fluoride; 25%
glycerol). Cell lysate was kept on ice for 20
min and lysed by two freeze/thaw cycles.
Cells were centrifuged for 10 min at 12,000
rpm, and the supernatant was kept at –80°C.
Immunoprecipitations were performed with
150 µg cell lysates for 3–4 hr at 4°C; 1 µg of
antibody was used. Immunocomplexes were
precipitated with protein A-Sepharose beads
(Sigma, St. Louis, MO, USA) and washed 4
times with washing buffer (10 mM Tris–HCl,
pH 8.0; 50 mM NaCl; 1 mM EDTA; 0.5%
nonidet P40) (30). Immunocomplexes were
washed in 1￿ kinase buffer and the pellet was
Figure 1. Induction of apoptosis by FB1. (A) CV-1 cells were transfected with plasmid pCMV-β-gal. After transfection,
cells were treated with 25 µM FB1 for 48 hr, ﬁxed, and stained with Bluo-gal for 24 hr. Cultures treated with PBS are
designated as controls. Magniﬁcation ￿100. (B) CV-1 cells were treated with 25 µM FB1 for 24 or 48 hr. High molecu-
lar weight DNA was prepared from CV-1 cells and electrophoresed on a 2% agarose gel; Southern blot analysis was
performed using monkey DNA as a probe. Cultures not treated with FB1 are designated as “C.” Molecular weight
markers are shown to the right.
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suspended in 10 µL of the same buffer (10￿
kinase buffer: 500 mM Tris, 250 mM Mg
acetate, 25 mM EDTA). The kinase reaction
contained 10 µCi γ-32P-adenosine triphos-
phate (ATP), 0.1 M ATP, 2.7 µg of histone
H1, and 100 µg crude extract diluted in 1￿
kinase buffer. After 30 min at 30°C, the reac-
tion was stopped by addition of 25 µL of
SDS–polyacrylamide gel electrophoresis
(PAGE) loading buffer. Reaction products
were analyzed by SDS–PAGE, and the gel
was dried and autoradiographed. Kinase
activity was measured with a PhosphorImager
instrument (Molecular Dynamics, Sunnyvale,
CA, USA). 
Analysis of Chloramphenicol
Acetyltransferase Activity 
CV-1 cells were transfected with the desig-
nated plasmids by calcium phosphate transfec-
tion as described previously (27,34,39).
Following transfection, cultures were treated
with 5 µM FB1. Forty hours after transfection,
cells were washed in PBS and a cell-free lysate
was prepared by three freeze–thaw cycles in
0.25 M Tris (pH 7.8). Chlorophenicol
acetyltranseferase (CAT) enzymatic activity
was measured as described previously (39).
After thin-layer chromatography, the amount
of 14C-chloramphenicol (CM), acetylated
or unacetylated, was measured with a
PhosphorImager device.
Statistical Analysis
Statistical analyses were performed using
Instat (Sigma Plot, Chicago, IL, USA), a per-
sonal computer software program. Results
were considered statistically signiﬁcant when
the p value was < 0.05.
Results
Identiﬁcation of Genes That Inhibit
Fumonisin B1-Induced Apoptosis
By using a battery of well-accepted assays that
identify apoptotic cells, several independent
studies have concluded that FB1 induces
apoptosis in CV-1 cells (29) and human cells
(26–29). To identify genes that regulate
apoptosis, we used an assay based on co-
transfecting cells with a β-gal expression plas-
mid (pCMV-β-gal) and a gene that regulates
apoptosis (35,40,41). If a gene induces apop-
tosis, the number of β-gal+ cells decrease.
Conversely, anti-apoptotic genes increase the
number of β-gal+ cells following induction of
apoptosis, relative to controls. FB1 consis-
tently reduced the number of β-gal+ cells in
CV-1 cells (Figure 1A). Reduction of β-gal+
cells correlated with apoptosis because nucle-
osome-length DNA and higher molecular
weight forms of degraded DNA accumulated
24 or 48 hr after treatment (Figure 1B, lanes
24 or 48). As expected, untreated CV-1 cells
contained low levels of degraded DNA
(Figure 1B, lane C). 
In CV-1 cells, the baculovirus inhibitor of
apoptosis (CpIAP) efﬁciently inhibited FB1-
induced apoptosis (Figure 2). The Bcl-2 gene
did not effectively inhibit apoptosis by FB1.
Two caspase inhibitors, crmA and p35,
appeared to give slightly different results. p35
consistently inhibited FB1-induced apoptosis
slightly better than crmA in CV-1 cells. The
adenovirus E1B gene encodes a 55-kDa pro-
tein that binds and inactivates the p53
tumor-suppressor protein [reviewed in (33)].
E1B protected cells from apoptosis by FB1
but not as efﬁciently as CpIAP. As expected,
the adenovirus E1A gene induced apoptosis
and FB1 had little or no effect on this process.
In summary, these studies indicated that
CpIAP efﬁciently inhibited apoptosis by FB1. 
FB1-Induced Apoptosis 
Does Not Require p53
To determine whether p53 was required for
FB1-induced apoptosis, studies were per-
formed in MEF derived from p53–/– mice
and subsequently compared to results
obtained in p53+/+ MEF. The studies pre-
sented in Figure 2 indicated that E1B did
not completely prevent apoptosis by FB1,
suggesting p53 was important but not
required. We were particularly interested in
determining whether p53 was required for
FB1-induced apoptosis because of the
importance p53 plays in apoptosis and cell
growth. p53–/– cells are ideal for these
studies because they are low-passage cells
that lack only p53, whereas many estab-
lished cells lacking p53 have additional
unidentified mutations. Treatment of
p53–/–cells with 25 µM FB1 for 24 hr led to
the appearance of the typical DNA ladder
characteristic of apoptosis (Figure 3A).
When lower concentrations of FB1 were
used (5 µM), apoptosis occurred but at a
lower efﬁciency (data not shown). The β-gal
transfection assay also demonstrated that 25
µM FB1 reduced the number of β-gal+ cells
(Figure 3B), and CpIAP protected p53–/–
cells from apoptosis. p35 and CpIAP pro-
tected both MEF more efficiently from
apoptosis relative to crmA. Bcl-2 protected
p53–/– MEF more effectively than p53+/+
MEF from FB1-induced apoptosis.
Although p53 was not absolutely required
for apoptosis induced by FB1, it appeared to
have an effect on the ability of Bcl-2 to
inhibit apoptosis. 
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Figure 2. Interference of FB1-induced apoptosis in CV-1
cells. CV-1 cells were co-transfected with plasmid
pCMV-β-gal (2 µg DNA) and plasmids expressing the
indicated apoptotic regulatory proteins (2 µg of the indi-
cated plasmid). After transfection, cells were treated
with 25 µM FB1 for 48 hr, ﬁxed, and stained with Bluo-
gal for 24 hr. The number of β-gal+ cells in five fields
was determined. The percentage of β-gal+ colonies was
normalized based on the number of blue cells in the
untreated control. The data in this study were derived
from ﬁve independent studies. The error bars show the
standard error of the mean. The differences between
E1B, p35, crmA, or CpIAP and the control are signiﬁcant
(p < 0.05).
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Figure 3. Analysis of apoptosis in MEF after FB1 treatment. (A) Genomic DNA was prepared from p53–/– MEF after
treatment with 25 µM FB1 for 24 hr. As a control, DNA was prepared from untreated cells (U). DNA was separated on
2% agarose gels, and the DNA was stained with ethidium bromide. The position and size (Kb) of the marker DNA (M)
is indicated. (B) p53–/–or p53+/+ MEF were co-transfected with pCMV-β-gal (2 µg DNA) and a plasmid expressing the
indicated apoptotic regulatory proteins (2 µg). Cultures were treated with 25 uM FB1 after transfection. The results
are the mean of ﬁve independent experiments. The arrow bars show the standard error of the mean. The differences
between p35, Bcl-2, or CpIAP and the control are signiﬁcant (p < 0.05).
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Analysis of the TNF Pathway after 
FB1Treatment
CpIAP interferes with TNF/Fas induced apop-
tosis by binding to caspase 3, a direct target of
caspase 8 and 9 [reviewed in (42); summarized
in Figure 4]. This suggested the ability of
CpIAP to efficiently inhibit FB1 induced
apoptosis was because the TNF signaling path-
way was involved. However, CpIAP also binds
directly to caspase 9 and 7, suggesting that
FB1-induced apoptosis was not directly related
to the TNF/Fas signaling pathway. Caspases
are important for apoptosis because they
degrade proteins necessary for cell survival.
Because caspase 8 is required for TNF/Fas-
induced apoptosis and it must be cleaved to be
activated (43), we tested whether caspase 8 was
cleaved after FB1 treatment. An antibody that
recognizes intact and cleaved caspase 8 was
used for this study. At 2 and 6 hr after FB1
treatment, a slight increase in the amount of
cleaved caspase 8 (10-kDa band) was observed
in CV-1 cells treated with 25 µM FB1 (Figure
5). Although similar levels of uncleaved caspase
8 were seen in control cultures, the amount of
the 10-kDa band was lower.
NF-κB activation can also occur following
TNFR activation, but different accessory pro-
teins are involved [(42); summarized in Figure
4]. In contrast to caspase 8 cleavage, activation
of NF-κB appears to be related to cell survival
(41). Consequently, we tested whether FB1
treatment had any effect on NF-κB activity.
For this study, we used the HIVLTR and an
NF-κB mutant (HIV∆NFκB). At 3, 24, or 48
hr after FB1 treatment, neither plasmid had
higher promoter activity (Figure 6). In con-
trast, infection of cells transfected with HIV
LTR with herpes simplex virus type 1 led to
higher levels of HIV LTR promoter activity,
as described previously (44). Under identical
conditions we previously demonstrated that
the promoter regulating the cdk inhibitor
(p21) was activated by FB1 treatment (39). In
summary, caspase 8 but not NF-κB was acti-
vated by FB1 treatment.
Transient Activation of cdk2 
by FB1Treatment
A previous study demonstrated that FB1 treat-
ment inhibited cdk2 activity in CV-1 cells
(30). This same study suggested that 3 hr after
FB1 treatment a slight increase in cdk2 activ-
ity occurred. This may be important because
cdk activity increases during the early stages of
apoptosis (32,45). To test whether FB1 treat-
ment increased cdk2 levels transiently, cdk2
activity was analyzed at different times during
the early stages of treatment. Relative to con-
trol cultures, cdk2 activity increased at least 2-
fold between 2 and 4 hr after treatment but
then rapidly declined (Figure 7). In contrast,
cdk2 activity was not stimulated for 4–8 hr
after CV-1 cells were plated in normal media.
As expected, the amount of cdk2 activity con-
tinued to increase after serum treatment. In
summary, this study demonstrated that cdk2
activity increased 2- to 3-fold at 2 and 4 hr
after FB1 treatment.
Discussion
In this study, the mechanism by which FB1
induced apoptosis was examined in CV-1,
p53–/– MEF, and p53+/+ MEF. Induction of
apoptosis by FB1 does not appear to require
p53 because p53–/– MEF undergo apoptosis
following treatment (Figure 3), and the E1B
55-kDa protein did not completely inhibit
apoptosis (Figures 2, 3). In p53–/–cells, Bcl-2
protected cells from apoptosis more effi-
ciently (Figure 3B), suggesting that under
certain circumstances Bcl-2 can interfere with
Figure 4. Schematic of TNF/Fas signal transduction pathway. See text for details.
Figure 5. Cleavage of caspase 8 after FB1 treatment.
CV-1 cells were treated with FB1 for the designated
time, whole cell extracts prepared, and 50 µg protein run
on a 12% SDS–PAGE (30). Western blots were probed
with an antibody directed against caspase 8
(PharMingen catalog 66231A, BD PharMingen, San
Diego, CA, USA). The circle represents uncleaved cas-
pase 8, the arrow at 20 kDa a putative breakdown prod-
uct, and the block arrow the 10-kDa caspase 8
proteolytic breakdown product. This Western blot is rep-
resentative of three independent experiments.
Figure 6. FB1 treatment has no effect on NF-κB tran-
scriptional activity. CV-1 cells were transfected with the
designated constructs. Following transfection, cells were
treated with FB1 (5 µM) such that the treatment lasted
until 48 hr after transfection. CAT enzymatic activity was
measured as described previously (39,52). The amount of
acetylated chloramphenicol activity (Ac-CM) was quanti-
ﬁed in a PhosphorImager. The results are representative
of three independent experiments.
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FB1-induced apoptosis. p53 transactivates
expression of BAX (46), a pro-apoptotic gene.
We hypothesize that in the absence of p53,
BAX levels are lower, and under these circum-
stances Bcl-2 can efficiently inhibit murine
ﬁbroblasts from FB1-induced apoptosis. It is
also possible that Bcl-2 effectively inhibits
apoptosis if an unknown cofactor is present. 
FB1-induced apoptosis was efficiently
inhibited by CpIAP in the cell lines tested.
CpIAP prevents apoptosis by interfering with
the TNF/Fas pathway or binding certain cas-
pases [reviewed in (33)]. Consequently, we
hypothesized that the TNF/Fas pathway may
be involved with FB1-induced apoptosis. The
TNFR1 recruits caspase 8, resulting in prote-
olytic activation of caspase 8, which subse-
quently activates a caspase cascade (Figure 4).
The finding that caspase 8 was cleaved fol-
lowing FB1 treatment (Figure 5) supports the
hypothesis that the TNF/Fas pathway was
activated. CpIAP also associates with the sig-
naling molecule TNFR-associated factor
(TRAF) and functions as a component of the
TNFR signaling complex (47). TNF-α binds
and activates TNFR, thus recruiting a
TRAF–CpIAP complex to the cytoplasmic
domain of TNFR. The TRAF–IAP complex
consequently interferes with death signals
activated by TNF. The recent ﬁnding that a
TNFR-associated protein (TRAP)-2 is
induced in CV-1 cells after FB1 treatment
lends support for the involvement of TNFR
(48). Because CpIAP can also bind to several
caspases and inhibit their protease activity
(42), it is possible that inactivation of certain
capsases by CpIAP inhibits FB1-induced
apoptosis. 
Although p35 and crmA are both caspase
inhibitors, p35 inhibits a broader spectrum of
caspases compared to crmA (49). IAP family
members physically interact with caspase 3, 7,
and 9 [reviewed in (33,42); Figure 4]. crmA
has been reported to bind to caspase 8, but
not caspase 9. crmA partially prevented apop-
tosis following FB1 treatment, suggesting that
the caspase 8 pathway is not the exclusive
determinant in apoptosis. Our results cannot
rule out the possibility that FB1 treatment
leads to activation of caspase 9, which is a
proximal caspase in mitochondria-mediated
apoptosis. Unlike caspase 8, we have not been
able to demonstrate that caspase 9 was
cleaved following FB1 treatment (data not
shown). Because caspase 9 activation requires
interaction with active Apaf-1, but not prote-
olytic activation (50), further experiments
will be necessary to determine if the caspase 9
signaling pathway is also involved with FB1-
induced apoptosis. 
The association of TNFR with other
factors, TNFR-associated death domain,
TRAF2, Fas-associated death domain, or
DAXX, can lead to apoptosis or NF-κB acti-
vation (41,51), which prevents cell death.
The ﬁnding that FB1 treatment did not lead
to NF-κB (Figure 6) or AP-1 activation (52)
suggested that FB1 treatment selectively acti-
vated components of the TNF pathway lead-
ing to cell death. When FB1 is injected
subcutaneously into mice (53), TNF-α activ-
ity increases. A TNF-α–like activity is also
induced in swine after FB1 injection (54).
Induction of TRAP2 in CV-1 cells but not
COS-7 cells (48) suggested that TRAP2 plays
an important role in FB1-mediated apoptosis.
Taken together, we hypothesize that induc-
tion of a TNF-like pathway in FB1-treated
cells has relevance to its toxic and carcino-
genic properties. Future experiments will
focus on identifying the factors in the TNF
pathway that are induced by FB1.
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